Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × Celecoxib × Clear all

NCT00293436 2012-09-17

Celecoxib and Erlotinib in Treating Patients With Liver Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00057980 2012-06-11

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms